|
93
|
348
|
1y6aA |
Crystal structure of vegfr2 in complex with a 2-anilino-5-aryl-oxazole inhibitor |
|
77
|
273
|
1yojA |
Crystal structure of src kinase domain |
|
92
|
293
|
1yhvA |
Crystal structure of pak1 kinase domain with two point mutations (k299r, t423e) |
|
82
|
273
|
1yhsA |
Crystal structure of pim-1 bound to staurosporine |
|
79
|
298
|
1y8yA |
Crystal structure of human cdk2 complexed with a pyrazolo[1,5-a]pyrimidine inhibitor |
|
65
|
279
|
1yomA |
Crystal structure of src kinase domain in complex with purvalanol a |
|
92
|
350
|
1y6bA |
Crystal structure of vegfr2 in complex with a 2-anilino-5-aryl-oxazole inhibitor |
|
79
|
278
|
1yolA |
Crystal structure of src kinase domain in complex with cgp77675 |
|
77
|
273
|
1yi3A |
Crystal structure of pim-1 bound to ly294002 |
|
108
|
336
|
1ydrE |
Structure of camp-dependent protein kinase, alpha-catalytic subunit in complex with h7 protein kinase inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine |
|
132
|
452
|
1y57A |
Structure of unphosphorylated c-src in complex with an inhibitor |
|
106
|
356
|
1yqjA |
Crystal structure of p38 alpha in complex with a selective pyridazine inhibitor |
|
76
|
273
|
1yi4A |
Structure of pim-1 bound to adenosine |
|
85
|
276
|
1yi6A |
C-term tail segment of human tyrosine kinase (258-533) |
|
109
|
336
|
1ydsE |
Structure of camp-dependent protein kinase, alpha-catalytic subunit in complex with h8 protein kinase inhibitor [n-(2-methylamino)ethyl]-5-isoquinolinesulfonamide |
|
91
|
293
|
1yhwA |
Crystal structure of pak1 kinase domain with one point mutations (k299r) |
|
82
|
277
|
1xqzA |
Crystal structure of hpim-1 kinase at 2.1 a resolution |
|
111
|
337
|
1xh5A |
Crystal structures of protein kinase b selective inhibitors in complex with protein kinase a and mutants |
|
87
|
320
|
1xjdA |
Crystal structure of pkc-theta complexed with staurosporine at 2a resolution |
|
108
|
338
|
1xh9A |
Crystal structures of protein kinase b selective inhibitors in complex with protein kinase a and mutants |
|
83
|
273
|
1xwsA |
Crystal structure of the human pim1 kinase domain |
|
87
|
317
|
1xkkA |
Egfr kinase domain complexed with a quinazoline inhibitor- gw572016 |
|
107
|
340
|
1xh7A |
Crystal structures of protein kinase b selective inhibitors in complex with protein kinase a and mutants |
|
105
|
337
|
1xh4A |
Crystal structures of protein kinase b selective inhibitors in complex with protein kinase a and mutants |
|
112
|
339
|
1xh8A |
Crystal structures of protein kinase b selective inhibitors in complex with protein kinase a and mutants |
|
83
|
277
|
1xr1A |
Crystal structure of hpim-1 kinase in complex with amp-pnp at 2.1 a resolution |
|
108
|
333
|
1xh6A |
Crystal structures of protein kinase b selective inhibitors in complex with protein kinase a and mutants |
|
69
|
295
|
1xo2B |
Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetin |
|
115
|
350
|
1xhaA |
Crystal structures of protein kinase b selective inhibitors in complex with protein kinase a and mutants |
|
83
|
279
|
1x8bA |
Structure of human wee1a kinase: kinase domain complexed with inhibitor pd0407824 |
|
78
|
273
|
1wvyA |
Crystal structures of kinase domain of dap kinase in complex with small molecular inhibitors |
|
82
|
275
|
1wvwA |
Crystal structures of kinase domain of dap kinase in complex with small molecular inhibitors |
|
87
|
275
|
1wvxA |
Crystal structures of kinase domain of dap kinase in complex with small molecular inhibitors |
|
70
|
303
|
1wmkA |
Human death-associated kinase drp-1, mutant s308d d40 |
|
86
|
274
|
1xbcA |
Crystal structure of the syk tyrosine kinase domain with staurosporin |
|
101
|
350
|
1wzyA |
Crystal structure of human erk2 complexed with a pyrazolopyridazine derivative |
|
107
|
347
|
1wfcA |
Structure of apo, unphosphorylated, p38 mitogen activated protein kinase p38 (p38 map kinase) the mammalian homologue of the yeast hog1 protein |
|
85
|
274
|
1xbaA |
Crystal structure of apo syk tyrosine kinase domain |
|
91
|
277
|
1xbbA |
Crystal structure of the syk tyrosine kinase domain with gleevec |
|
113
|
351
|
1wbtA |
Identification of novel p38 alpha map kinase inhibitors using fragment-based lead generation. |
|
76
|
298
|
1wccA |
Screening for fragment binding by x-ray crystallography |
|
110
|
351
|
1w82A |
P38 kinase crystal structure in complex with small molecule inhibitor |
|
93
|
276
|
1w2fA |
Human inositol (1,4,5)-trisphosphate 3-kinase substituted with selenomethionine |
|
85
|
302
|
1vywA |
Structure of cdk2/cyclin a with pnu-292137 |
|
102
|
372
|
1wbpA |
Srpk1 bound to 9mer docking motif peptide |
|
113
|
376
|
1wakA |
X-ray structure of srpk1 |
|
82
|
298
|
1w8cA |
Co-crystal structure of 6-cyclohexylmethoxy-8-isopropyl-9h-purin-2- ylamine and monomeric cdk2 |
|
79
|
298
|
1w0xC |
Crystal structure of human cdk2 in complex with the inhibitor olomoucine. |
|
111
|
351
|
1wbnA |
Fragment based p38 inhibitors |
|
112
|
351
|
1wbvA |
Identification of novel p38 alpha map kinase inhibitors using fragment-based lead generation. |